UBS Group’s Aterian ATER Stock Holding History
Bought
Maintained
Sold
Other funds holding ATER
BCM
XT
UBS Group's ATER Position: Q2 2026 in Review
UBS Group increased its Aterian (ATER) stake by 131% in Q2 2026, buying an estimated $7.47K and bringing the position to 12,704 shares worth $16.8K. The position accounts for ﹤0.01% of the portfolio, ranked #8259.
UBS Group first reported a position in ATER in Q2 2019 and has held it in 28 quarters since. The position peaked at $252K in Q4 2021. 24 funds tracked by Wall St. Rank hold ATER as of Q2 2026.
- UBS Group held 12,704 shares of Aterian worth $16.8K as of Q2 2026.
- UBS Group bought 7,205 Aterian shares in Q2 2026, an estimated $7.47K.
- Aterian made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #8259 holding.
- UBS Group first reported a position in Aterian in Q2 2019 and has held it in 28 quarters since.
- UBS Group's Aterian position peaked at $252K in Q4 2021.
- 24 funds tracked by Wall St. Rank held Aterian as of Q2 2026.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.